Trial Profile
Low-dose Propofol for the Treatment of Severe Refractory Migraine Headache in the Emergency Department
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 20 Mar 2020
Price :
$35
*
At a glance
- Drugs Propofol (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 08 May 2017 Status changed from recruiting to discontinued.
- 17 Jul 2015 New trial record